Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance
March 03, 2023 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports fourth quarter 2022 commercial revenue of $4.4 million Reports full year 2022 commercial revenue of $17.1 million Delivered full year 2022 recurring commercial revenue of $11.0 million,...
Rapid Micro Biosystems to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023 16:52 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023
February 16, 2023 16:05 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue
January 11, 2023 09:00 ET
|
Rapid Micro Biosystems, Inc.
Full year 2022 commercial revenue expected to be between $17.0 million and $17.2 million Finished 2022 with approximately $140 million in cash and investments providing runway at least into 2026 ...
Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023 08:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results
November 10, 2022 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2022 commercial revenue of $4.7 million Delivered year-over-year recurring revenue growth of 34% Reaffirms full year 2022 commercial revenue guidance of at least $17.0 million ...
Rapid Micro Biosystems to Announce Third Quarter 2022 Financial Results on November 10, 2022
November 02, 2022 08:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System
October 10, 2022 08:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference
October 04, 2022 08:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference
September 12, 2022 09:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...